{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:31:23Z","timestamp":1778509883974,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10067-025-07467-z","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:40:14Z","timestamp":1748529614000},"page":"2793-2808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring the potential mechanism of tofacitinib therapy for ankylosing spondylitis through gut microbiome and plasma metabolomics"],"prefix":"10.1007","volume":"44","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinmeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guixia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijia","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5039-5969","authenticated-orcid":false,"given":"Changhao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"7467_CR1","volume":"12","author":"CW Chen","year":"2021","unstructured":"Chen CW, Wei JC, Gu J, Yu D (2021) Editorial: Advances in pathogenesis, etiology, and therapies for ankylosing spondylitis. Front Immunol 12:822582","journal-title":"Front Immunol"},{"issue":"1","key":"7467_CR2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/BOR.0000000000000239","volume":"28","author":"F Ciccia","year":"2016","unstructured":"Ciccia F, Rizzo A, Triolo G (2016) Subclinical gut inflammation in ankylosing spondylitis. Curr Opin Rheumatol 28(1):89\u201396","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"7467_CR3","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/CM9.0000000000000696","volume":"133","author":"PX Wang","year":"2020","unstructured":"Wang PX, Deng XR, Zhang CH, Yuan HJ (2020) Gut microbiota and metabolic syndrome. Chin Med J 133(7):808\u2013816","journal-title":"Chin Med J"},{"issue":"5","key":"7467_CR4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/cells12050793","volume":"12","author":"J Wang","year":"2023","unstructured":"Wang J, Zhu N, Su X, Gao Y, Yang R (2023) Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis. Cells 12(5):793","journal-title":"Cells"},{"issue":"6","key":"7467_CR5","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3390\/nu13062099","volume":"13","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xu J, Chen Y (2021) Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients 13(6):2099","journal-title":"Nutrients"},{"key":"7467_CR6","doi-asserted-by":"crossref","first-page":"1007165","DOI":"10.3389\/fimmu.2022.1007165","volume":"13","author":"T Zhao","year":"2022","unstructured":"Zhao T, Wei Y, Zhu Y, Xie Z, Hai Q, Li Z, Qin D (2022) Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities. Front Immunol 13:1007165","journal-title":"Front Immunol"},{"key":"7467_CR7","doi-asserted-by":"crossref","unstructured":"Longo UG, Lalli A, Bandini B, de Sire R, Angeletti S, Lustig S, Ammendolia A, Budhiparama NC, de Sire A (2024) Role of the gut microbiota in osteoarthritis, rheumatoid arthritis, and spondylarthritis: an update on the gut-joint axis. Int J Mol Sci 25(6):3242","DOI":"10.3390\/ijms25063242"},{"key":"7467_CR8","doi-asserted-by":"crossref","first-page":"1154380","DOI":"10.3389\/fimmu.2023.1154380","volume":"14","author":"C Li","year":"2023","unstructured":"Li C, Zhang Y, Yan Q, Guo R, Chen C, Li S, Zhang Y, Meng J, Ma J, You W et al (2023) Alterations in the gut virome in patients with ankylosing spondylitis. Front Immunol 14:1154380","journal-title":"Front Immunol"},{"issue":"1","key":"7467_CR9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s13075-019-2018-4","volume":"21","author":"E Klingberg","year":"2019","unstructured":"Klingberg E, Magnusson MK, Strid H, Deminger A, St\u00e5hl A, Sundin J, Simr\u00e9n M, Carlsten H, \u00d6hman L, Forsblad-d\u2019Elia H (2019) A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin. Arthritis Res Ther 21(1):248","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"7467_CR10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41584-022-00761-z","volume":"18","author":"A Danve","year":"2022","unstructured":"Danve A, Deodhar A (2022) Treatment of axial spondyloarthritis: an update. Nat Rev Rheumatol 18(4):205\u2013216","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"7467_CR11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/1744666X.2022.2038134","volume":"18","author":"R Mohanakrishnan","year":"2022","unstructured":"Mohanakrishnan R, Beier S, Deodhar A (2022) Tofacitinib for the treatment of active ankylosing spondylitis in adults. Expert Rev Clin Immunol 18(3):273\u2013280","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"7467_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landew\u00e9 RBM, Van den Bosch FE, Boteva B, Bremander A et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82(1):19\u201334","journal-title":"Ann Rheum Dis"},{"key":"7467_CR13","doi-asserted-by":"crossref","unstructured":"Magrey MN, Kiltz U (2019) Chapter 9 - Clinical assessment of axial spondyloarthritis. In:\u00a0Mease P, Khan MA (eds) Axial Spondyloarthritis. edn. Elsevier, pp 121\u2013133","DOI":"10.1016\/B978-0-323-56800-5.00009-6"},{"key":"7467_CR14","unstructured":"The Bath Indices (2021) Physiopedia. Retrieved February 27, 2025, from https:\/\/www.physio-pedia.com\/index.php?title=The_Bath_Indices&oldid=275446"},{"issue":"1","key":"7467_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado P, Landew\u00e9 R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70(1):47\u201353","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"7467_CR16","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1526-4637.2012.01498.x","volume":"13","author":"TM Atkinson","year":"2012","unstructured":"Atkinson TM, Halabi S, Bennett AV, Rogak L, Sit L, Li Y, Kaplan E, Basch E (2012) Measurement of affective and activity pain interference using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903. Pain medicine (Malden, Mass) 13(11):1417\u20131424","journal-title":"Pain Med (Malden, Mass)"},{"issue":"Suppl 11","key":"7467_CR17","first-page":"S47","volume":"63","author":"J Zochling","year":"2011","unstructured":"Zochling J (2011) Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res 63(Suppl 11):S47-58","journal-title":"Arthritis Care Res"},{"issue":"4","key":"7467_CR18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.berh.2007.02.010","volume":"21","author":"J Zochling","year":"2007","unstructured":"Zochling J, Braun J (2007) Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol 21(4):699\u2013712","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"7467_CR19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/acr.24465","volume":"74","author":"F Hirano","year":"2022","unstructured":"Hirano F, Landew\u00e9 RBM, van Gaalen FA, van der Heijde D, Gaujoux-Viala C, Ramiro S (2022) Determinants of the physician global assessment of disease activity and influence of contextual factors in early axial spondyloarthritis. Arthritis Care Res 74(2):268\u2013273","journal-title":"Arthritis Care Res"},{"key":"7467_CR20","volume":"13","author":"J Shen","year":"2022","unstructured":"Shen J, Yang L, You K, Chen T, Su Z, Cui Z, Wang M, Zhang W, Liu B, Zhou K et al (2022) Indole-3-acetic acid alters intestinal microbiota and alleviates ankylosing spondylitis in mice. Front Immunol 13:762580","journal-title":"Front Immunol"},{"key":"7467_CR21","volume":"12","author":"Q Yan","year":"2021","unstructured":"Yan Q, Chen W, Song H, Long X, Zhang Z, Tang X, Chen H, Lin H, Sun L (2021) Tofacitinib ameliorates lupus through suppression of T cell activation mediated by TGF-beta type I receptor. Front Immunol 12:675542","journal-title":"Front Immunol"},{"issue":"8","key":"7467_CR22","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s10067-021-05679-7","volume":"40","author":"MC Hwang","year":"2021","unstructured":"Hwang MC, Ridley L, Reveille JD (2021) Ankylosing spondylitis risk factors: a systematic literature review. Clin Rheumatol 40(8):3079\u20133093","journal-title":"Clin Rheumatol"},{"issue":"1","key":"7467_CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13059-017-1271-6","volume":"18","author":"C Wen","year":"2017","unstructured":"Wen C, Zheng Z, Shao T, Liu L, Xie Z, Le Chatelier E, He Z, Zhong W, Fan Y, Zhang L et al (2017) Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. Genome Biol 18(1):142","journal-title":"Genome Biol"},{"issue":"1","key":"7467_CR24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15403\/jgld-2823","volume":"30","author":"A Cardoneanu","year":"2021","unstructured":"Cardoneanu A, Mihai C, Rezus E, Burlui A, Popa I, Cijevschi Prelipcean C (2021) Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis. J Gastrointest Liver Dis 30(1):46\u201354","journal-title":"J Gastrointest Liver Dis"},{"key":"7467_CR25","doi-asserted-by":"crossref","first-page":"1010572","DOI":"10.3389\/fimmu.2022.1010572","volume":"13","author":"ZY Song","year":"2022","unstructured":"Song ZY, Yuan D, Zhang SX (2022) Role of the microbiome and its metabolites in ankylosing spondylitis. Front Immunol 13:1010572","journal-title":"Front Immunol"},{"issue":"3","key":"7467_CR26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3748\/wjg.v29.i3.450","volume":"29","author":"CR Wang","year":"2023","unstructured":"Wang CR, Tsai HW (2023) Seronegative spondyloarthropathy-associated inflammatory bowel disease. World J Gastroenterol 29(3):450\u2013468","journal-title":"World J Gastroenterol"},{"issue":"1","key":"7467_CR27","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/s41467-020-15831-7","volume":"11","author":"N Tajik","year":"2020","unstructured":"Tajik N, Frech M, Schulz O, Sch\u00e4lter F, Lucas S, Azizov V, D\u00fcrholz K, Steffen F, Omata Y, Rings A et al (2020) Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat Commun 11(1):1995","journal-title":"Nat Commun"},{"issue":"22","key":"7467_CR28","first-page":"2591","volume":"14","author":"J De Avila","year":"2024","unstructured":"De Avila J, Fl\u00f3rez-Sarmiento C, Parra-Izquierdo V, Bautista-Molano W, Chamorro-Melo M, Beltr\u00e1n-Ostos A, Jaimes DA, Khoury V, Chila-Moreno L, Ramos-Casallas A et al (2024) Elevated calprotectin levels reveal loss of vascular pattern and atrophy of villi in ileum by digital chromoendoscopy and magnification colonoscopy in patients with spondyloarthritis without having inflammatory bowel disease. Diagnostics (Basel, Switzerland) 14(22):2591","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"1","key":"7467_CR29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/art.42658","volume":"76","author":"M Essex","year":"2024","unstructured":"Essex M, Rios Rodriguez V, Rademacher J, Proft F, L\u00f6ber U, Mark\u00f3 L, Pleyer U, Strowig T, Marchand J, Kirwan JA et al (2024) Shared and distinct gut microbiota in spondyloarthritis, acute anterior uveitis, and Crohn\u2019s disease. Arthritis Rheumatol (Hoboken, NJ) 76(1):48\u201358","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"5","key":"7467_CR30","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3904\/kjim.2015.313","volume":"32","author":"SM Ahn","year":"2017","unstructured":"Ahn SM, Kim YG, Bae SH, Lim DH, Hong S, Park SH, Lee CK, Yoo B (2017) Ileocolonoscopic findings in patients with ankylosing spondylitis: a single center retrospective study. Korean J Intern Med 32(5):916\u2013922","journal-title":"Korean J Intern Med"},{"issue":"3","key":"7467_CR31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/00325481.2022.2041338","volume":"134","author":"HY Feng","year":"2022","unstructured":"Feng HY, Chan CH, Chu YC, Qu XM, Wang YH, Wei JC (2022) Patients with ankylosing spondylitis have high risk of irritable bowel syndrome: a long-term nationwide population-based cohort study. Postgrad Med 134(3):290\u2013296","journal-title":"Postgrad Med"},{"key":"7467_CR32","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3390\/ijms17122126","volume":"17","author":"L Yang","year":"2016","unstructured":"Yang L, Wang L, Wang X, Xian CJ, Lu H (2016) A possible role of intestinal microbiota in the pathogenesis of ankylosing spondylitis. Int J Mol Sci 17:2126","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7467_CR33","doi-asserted-by":"crossref","first-page":"2458184","DOI":"10.1080\/19490976.2025.2458184","volume":"17","author":"R Zhang","year":"2025","unstructured":"Zhang R, Tang Y, Feng X, Lu X, Zhao M, Jin J, Ji X, He H, Zhao L (2025) Targeted modulation of intestinal barrier and mucosal immune-related microbiota attenuates IgA nephropathy progression. Gut Microbes 17(1):2458184","journal-title":"Gut Microbes"},{"issue":"1","key":"7467_CR34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13073-016-0303-2","volume":"8","author":"CL Boulang\u00e9","year":"2016","unstructured":"Boulang\u00e9 CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME (2016) Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med 8(1):42","journal-title":"Genome Med"},{"issue":"1","key":"7467_CR35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40168-024-01808-x","volume":"12","author":"X Xiao","year":"2024","unstructured":"Xiao X, Zhou Y, Li X, Jin J, Durham J, Ye Z, Wang Y, Hennig B, Deng P (2024) (13)C-Stable isotope resolved metabolomics uncovers dynamic biochemical landscape of gut microbiome-host organ communications in mice. Microbiome 12(1):90","journal-title":"Microbiome"},{"issue":"6","key":"7467_CR36","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.3390\/ijms22063076","volume":"22","author":"L Aldars-Garc\u00eda","year":"2021","unstructured":"Aldars-Garc\u00eda L, Marin AC, Chaparro M, Gisbert JP (2021) The interplay between immune system and microbiota in inflammatory bowel disease: a narrative review. Int J Mol Sci 22(6):3076","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7467_CR37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.29262\/ram.v71i1.1305","volume":"71","author":"C Romero-S\u00e1nchez","year":"2024","unstructured":"Romero-S\u00e1nchez C, Ferrer-Santos C, Abril D, Acosta-Hern\u00e1ndez E, \u00c1vila J, Ramos-Casallas A, Escobar J, Bautista-Molano W, Jaimes D, Beltr\u00e1n-Ostos A et al (2024) Faecal microbiota study reveals specific dysbiosis in spondyloarthritis according to subtype, disease activity and treatment. Revi Alerg Mex (Tecamachalco, Puebla, Mexico\u202f: 1993) 71(1):81","journal-title":"Revi Alerg Mex (Tecamachalco, Puebla, Mexico : 1993)"},{"issue":"20","key":"7467_CR38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.21037\/atm.2019.09.41","volume":"7","author":"Z Chen","year":"2019","unstructured":"Chen Z, Qi J, Wei Q, Zheng X, Wu X, Li X, Liao Z, Lin Z, Gu J (2019) Variations in gut microbial profiles in ankylosing spondylitis: disease phenotype-related dysbiosis. Ann Transl Med 7(20):571","journal-title":"Ann Transl Med"},{"key":"7467_CR39","first-page":"8884324","volume":"2020","author":"G Liu","year":"2020","unstructured":"Liu G, Hao Y, Yang Q, Deng S (2020) The association of fecal microbiota in ankylosing spondylitis cases with C-reactive protein and erythrocyte sedimentation rate. Mediators Inflamm 2020:8884324","journal-title":"Mediators Inflamm"},{"issue":"9","key":"7467_CR40","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s10067-020-05032-4","volume":"39","author":"F Zhang","year":"2020","unstructured":"Zhang F, Ma C, Zhang B, Bi L (2020) Dynamic changes in gut microbiota under the influence of smoking and TNF-\u03b1-blocker in patients with ankylosing spondylitis. Clin Rheumatol 39(9):2653\u20132661","journal-title":"Clin Rheumatol"},{"issue":"1","key":"7467_CR41","doi-asserted-by":"crossref","first-page":"13480","DOI":"10.1038\/s41598-023-39055-z","volume":"13","author":"C Nieto-Clavijo","year":"2023","unstructured":"Nieto-Clavijo C, Morales L, Marquez-Ortiz RA, Romero-S\u00e1nchez C, Ramos-Casallas A, Escobar-Perez J, Bautista-Molano W, Bello-Gualtero JM, Chaparro-Olaya J (2023) Differential gut microbiome in spondyloarthritis patients associated to blastocystis colonization. Sci Rep 13(1):13480","journal-title":"Sci Rep"},{"issue":"1","key":"7467_CR42","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3892\/etm.2021.10108","volume":"22","author":"A Cardoneanu","year":"2021","unstructured":"Cardoneanu A, Cozma S, Rezus C, Petrariu F, Burlui AM, Rezus E (2021) Characteristics of the intestinal microbiome in ankylosing spondylitis. Exp Ther Med 22(1):676","journal-title":"Exp Ther Med"},{"issue":"2","key":"7467_CR43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.46497\/ArchRheumatol.2023.9124","volume":"38","author":"Y You","year":"2023","unstructured":"You Y, Zhang W, Cai M, Guo Q, Wang J, Cai Y, Lin J (2023) Discovery of fecal microbial signatures in patients with ankylosing spondylitis. Arch Rheumatol 38(2):217\u2013229","journal-title":"Arch Rheumatol"},{"issue":"15","key":"7467_CR44","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.3390\/jcm10153354","volume":"10","author":"G Scalise","year":"2021","unstructured":"Scalise G, Ciancio A, Mauro D, Ciccia F (2021) Intestinal microbial metabolites in ankylosing spondylitis. J Clin Med 10(15):3354","journal-title":"J Clin Med"},{"issue":"10","key":"7467_CR45","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/art.40183","volume":"69","author":"M Asquith","year":"2017","unstructured":"Asquith M, Davin S, Stauffer P, Michell C, Janowitz C, Lin P, Ensign-Lewis J, Kinchen JM, Koop DR, Rosenbaum JT (2017) Intestinal metabolites are profoundly altered in the context of HLA-B27 expression and functionally modulate disease in a rat model of spondyloarthritis. Arthritis Rheumatol (Hoboken, NJ) 69(10):1984\u20131995","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"9","key":"7467_CR46","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1039\/b807369d","volume":"133","author":"P Gao","year":"2008","unstructured":"Gao P, Lu C, Zhang F, Sang P, Yang D, Li X, Kong H, Yin P, Tian J, Lu X et al (2008) Integrated GC-MS and LC-MS plasma metabonomics analysis of ankylosing spondylitis. Analyst 133(9):1214\u20131220","journal-title":"Analyst"},{"issue":"1","key":"7467_CR47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/biomedicines11010047","volume":"11","author":"Z Li","year":"2022","unstructured":"Li Z, Gu W, Wang Y, Qin B, Ji W, Wang Z, Liu S (2022) Untargeted lipidomics reveals characteristic biomarkers in patients with ankylosing spondylitis disease. Biomedicines 11(1):47","journal-title":"Biomedicines"},{"issue":"1","key":"7467_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2009.01514.x","volume":"294","author":"P Louis","year":"2009","unstructured":"Louis P, Flint HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294(1):1\u20138","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"7467_CR49","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/s41467-020-18262-6","volume":"11","author":"W Yang","year":"2020","unstructured":"Yang W, Yu T, Huang X, Bilotta AJ, Xu L, Lu Y, Sun J, Pan F, Zhou J, Zhang W et al (2020) Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun 11(1):4457","journal-title":"Nat Commun"},{"issue":"4","key":"7467_CR50","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1159\/000490981","volume":"47","author":"W Feng","year":"2018","unstructured":"Feng W, Wu Y, Chen G, Fu S, Li B, Huang B, Wang D, Wang W, Liu J (2018) Sodium butyrate attenuates diarrhea in weaned piglets and promotes tight junction protein expression in colon in a GPR109A-dependent manner. Cell Physiol Biochem 47(4):1617\u20131629","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"7467_CR51","doi-asserted-by":"crossref","first-page":"14430","DOI":"10.1038\/s41598-018-32860-x","volume":"8","author":"M Luu","year":"2018","unstructured":"Luu M, Weigand K, Wedi F, Breidenbend C, Leister H, Pautz S, Adhikary T, Visekruna A (2018) Regulation of the effector function of CD8(+) T cells by gut microbiota-derived metabolite butyrate. Sci Rep 8(1):14430","journal-title":"Sci Rep"},{"issue":"6","key":"7467_CR52","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang PV, Hao L, Offermanns S, Medzhitov R (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 111(6):2247\u20132252","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"7467_CR53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41467-017-02490-4","volume":"9","author":"S Lucas","year":"2018","unstructured":"Lucas S, Omata Y, Hofmann J, B\u00f6ttcher M, Iljazovic A, Sarter K, Albrecht O, Schulz O, Krishnacoumar B, Kr\u00f6nke G et al (2018) Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun 9(1):55","journal-title":"Nat Commun"},{"issue":"12","key":"7467_CR54","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1158\/2326-6066.CIR-21-0459","volume":"9","author":"C Han","year":"2021","unstructured":"Han C, Ge M, Ho PC, Zhang L (2021) Fueling T-cell antitumor immunity: amino acid metabolism revisited. Cancer Immunol Res 9(12):1373\u20131382","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"7467_CR55","volume":"8","author":"W Ren","year":"2017","unstructured":"Ren W, Liu G, Yin J, Tan B, Wu G, Bazer FW, Peng Y, Yin Y (2017) Amino-acid transporters in T-cell activation and differentiation. Cell Death Dis 8(3):e2655","journal-title":"Cell Death Dis"},{"key":"7467_CR56","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/IJGM.S435650","volume":"17","author":"H Liu","year":"2024","unstructured":"Liu H, Peng Y (2024) Identification of a novel gene expression signature associated with amino acid metabolism (AAM) in ankylosing spondylitis (AS). Int J Gen Med 17:597\u2013609","journal-title":"Int J Gen Med"},{"issue":"10","key":"7467_CR57","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/metabo13101058","volume":"13","author":"Y Guo","year":"2023","unstructured":"Guo Y, Wei S, Yin M, Cao D, Li Y, Wen C, Zhou J (2023) Gas chromatography-mass spectrometry reveals stage-specific metabolic signatures of ankylosing spondylitis. Metabolites 13(10):1058","journal-title":"Metabolites"},{"key":"7467_CR58","volume":"12","author":"J Ou","year":"2021","unstructured":"Ou J, Xiao M, Huang Y, Tu L, Chen Z, Cao S, Wei Q, Gu J (2021) Serum metabolomics signatures associated with ankylosing spondylitis and TNF Inhibitor Therapy. Front Immunol 12:630791","journal-title":"Front Immunol"},{"issue":"1","key":"7467_CR59","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13075-016-1139-2","volume":"18","author":"W Wang","year":"2016","unstructured":"Wang W, Yang GJ, Zhang J, Chen C, Jia ZY, Li J, Xu WD (2016) Plasma, urine and ligament tissue metabolite profiling reveals potential biomarkers of ankylosing spondylitis using NMR-based metabolic profiles. Arthritis Res Ther 18(1):244","journal-title":"Arthritis Res Ther"},{"key":"7467_CR60","volume":"128","author":"B Liu","year":"2024","unstructured":"Liu B, Wang K, Yang L, Zheng J, Ma T, Zhang S, Huang L, Chen T, Guo Y, Cui Z et al (2024) 6-formylindolo[3, 2-b]carbazole alters gut microbiota and prevents the progression of ankylosing spondylitis in mice. Int Immunopharmacol 128:111562","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"7467_CR61","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/ard.2005.044065","volume":"65","author":"A J\u00fcngel","year":"2006","unstructured":"J\u00fcngel A, Baresova V, Ospelt C, Simmen BR, Michel BA, Gay RE, Gay S, Seemayer CA, Neidhart M (2006) Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis. Ann Rheum Dis 65(7):910\u2013912","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7467_CR62","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.3892\/mmr.2016.5523","volume":"14","author":"H Qu","year":"2016","unstructured":"Qu H, Li J, Wu LD, Chen WP (2016) Trichostatin A increases the TIMP-1\/MMP ratio to protect against osteoarthritis in an animal model of the disease. Mol Med Rep 14(3):2423\u20132430","journal-title":"Mol Med Rep"},{"issue":"1","key":"7467_CR63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13018-022-03224-z","volume":"17","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, He R, Liu Y, Luo T, Li Q, He Y, Fang M, Wang T (2022) HDAC1 regulates inflammation and osteogenic differentiation of ankylosing spondylitis fibroblasts through the Wnt-Smad signaling pathway. J Orthop Surg Res 17(1):343","journal-title":"J Orthop Surg Res"},{"key":"7467_CR64","volume":"2015","author":"XY Liu","year":"2015","unstructured":"Liu XY, Xu JF (2015) Reduced histone H3 acetylation in CD4(+) T lymphocytes: potential mechanism of latent autoimmune diabetes in adults. Dis Markers 2015:285125","journal-title":"Dis Markers"},{"issue":"9","key":"7467_CR65","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1248\/bpb.b22-00321","volume":"45","author":"W Zhe","year":"2022","unstructured":"Zhe W, Hoshina N, Itoh Y, Tojo T, Suzuki T, Hase K, Takahashi D (2022) A novel HDAC1-selective inhibitor attenuates autoimmune arthritis by inhibiting inflammatory cytokine production. Biol Pharm Bull 45(9):1364\u20131372","journal-title":"Biol Pharm Bull"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07467-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07467-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07467-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T07:46:42Z","timestamp":1751874402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07467-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["7467"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07467-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Laboratory Animal Management and Ethics Committee (2023\u2013047) and Ethics Committee of Bengbu Medical College (2022\u2013241), and all methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}